Ventyx Biosciences Inc expected to post a loss of 55 cents a share - Earnings Preview

Ventyx Biosciences

10/08/2024 01:05

* Ventyx Biosciences Inc  VTYX.OQ   VTYX.O  is expected
to show no
change in quarterly revenue when it reports  results on November
4 (estimated) for the period ending January 1 0001
    * 
    * ​LSEG's mean analyst estimate for Ventyx Biosciences Inc
is for
a loss of 55 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts had risen by
about 2.7%
in the last three months. ​
    * Wall Street's median 12-month price target for Ventyx
Biosciences Inc is $10.00​, above​ its last closing price
of $2.07. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Jun. 30 2024  -0.57       -0.58      -0.45     Beat    22.2
 Mar. 31 2024  -0.68       -0.69      -0.62     Beat    9.7
 Dec. 31 2023  -0.91       -0.90      -0.79     Beat    12.5​
 Jan. 1 0001   -0.89       -0.90      -0.92     Missed  -2.7
 ​​Jun.        -0.72       -0.71      -0.91     Missed  -28
 30 2023                                                
 Mar. 31 2023  -0.65       -0.65      -0.68     Missed  -5​
 Dec. 31 2022  -0.67       -0.63      -0.62     Beat    0.8
 Sep. 30 2022  -0.43       -0.44      -0.59     Missed  -33.7
 This summary was machine generated August 10 at 00:05 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)